$6.72
0.131.9%
Last update: Nov 9, 3:07 PM
Ocular Therapeutix Inc
OCULNASDAQ
The average analyst price target for Ocular Therapeutix is $22.19, 230.2% above the current price. Of 13 analysts, 13 rate it Buy. Targets range from $14 to $31. The latest change came on Oct 12, 2026, when UBS initiated coverage of Ocular Therapeutix with a Buy rating and a $14 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
